Prof. Ali Mohammad Sharifi is a scholar with over 27 years of experience in Molecular Pharmacology at the Iran University of Medical Sciences and currently joined as a professor of regenerative Medicine in the Tissue Engineering Group at NOCERAL, department of Orthopedics Surgery, School of Medicine. He obtained his Ph.D. from the University of Glasgow in 1992 and in 2018, he further enriched his expertise by acquiring a Tissue Banking Diploma from the National University of Singapore. Throughout his career, Prof. Sharifi has undertaken international research, including working at McGill University in Canada and at Max Plank Institute in Germany. His research output includes over 100 publications in high-impact journals, along with several patented innovations. He has held various administrative and editorial roles in academia, and has served as a peer reviewer for numerous high-impact journals. His dedication to education is evident through his mentorship of undergraduate and postgraduate students, particularly Ph.D. candidates specializing in molecular medicine, tissue engineering, molecular pharmacology, and cell therapy.  Prof. Sharifi's research expertise involves the fields of cell therapy and regenerative Pharmacology, with a particular emphasis on translational medicine. His extensive body of work includes pioneering studies on pharmacological priming, therapeutic angiogenesis, and innovative strategies to enhance the effectiveness of stem cell therapy by manipulating HIF-1α stabilization, especially in the context of diabetes. Additionally, his research activities include bone and cartilage regeneration, employing a diverse array of strategies such as stem cells and biologically derived products like amniotic membrane extract and mesenchymal stem cell-derived secretome. He has also explored the potential of herbal agents in regenerative medicine.  His contributions extend to the development of custom-made bio-implants for addressing large bone defects and the design and production of various wound dressings, with a specific focus on diabetic wound healing. In recent times, Prof. Sharifi has harnessed the transformative power of CRISPR gene editing technology to combat synovial fibrosis induced by osteoarthritis. In summary, Professor Sharifi is an active scientist in the field of Molecular Pharmacology and Regenerative Medicine, exemplifying innovation, and dedication to advancing scientific knowledge for improvement of healthcare and human well-being.  

Zamri obtained his BSc in Chemistry and MSc in pharmacology from the University of Malaya and later PhD in Clinical Pharmacology from the University of London (UK) in 2007. Soon after completed his doctorate degree, he joined the Department of pharmacology, University of Malaya as a senior lecturer and currently serves as a Professor in the Department of Pharmacology and also Head of Universiti Malaya Research Centre for Biopharmaceuticals and Advanced Therapeutics (UBAT). He was recently awarded a Fellow by the British Pharmacological Society (FBPhS). His scope of research includes bioavailability and pharmacokinetic studies in human and animal models, drug delivery systems such as PEG-PLGA nanoparticles for systemic drug delivery, and semi solid formulations for transdermal and topical preparation.  Apart from human clinical trials and preclinical studies in animals, his research also covers the development of humanized mice model for cancers and cell based therapy for cancers. His laboratory also provides services and research in adulterated pharmaceutical products, xenobiotic studies on certain chemicals such as endocrine disruptors in food products, human bodies, etc. using GCMS, HPLC, LCMSMS, etc. Apart from his research activities, he also actively provided consultation to local pharmaceutical companies to conduct testing on pharmaceutical formulations especially for bioequivalence studies, comparative dissolution, etc. His bioequivalence laboratory has conducted more than 40 bioequivalence studies for generic drug formulations and also conducted drug analysis in biological and pharmaceutical formulations.   

My academic career began on December 05, 2001 as a tutor at the Department of Islamic History and Civilization, APIUM. A year later I had completed my Usuluddin Master's Degree in Islamic History with a dissertation entitled "Dato' Haji Ismail Yusof: His Contribution to the Development of Islam in Kelantan". After completing my master's degree, I was assigned as a lecturer in the Department of Islamic History and Civilization on January 24, 2003 until now. In 2012, I have successfully graduated with a PhD degree from the same deparment after submitting a research thesis entitled "Majalah Pengasuh After Independence: A Study of Themes and Approaches". Throughout my career as a lecturer at Department of Islamic History and Civilization, I have actively written various articles in the fields of Islamic letters, the development of jawi writing, sirah nabawiah, Method of Islamic Biography Writing and Islamic civilization in addition to presenting papers at national or international seminars. Among the areas of research that have been carried out are on Jawi writing, Jawi-Islamic manuscripts, and Islamic letters, scholarly figures of the Malay Peninsula and the relationship between Malaysian and Indonesian Islamic institutions of higher education. I have written more than 60 papers in seminar proceedings, more than 125 articles that have been published in national and international journals, in addition to various activities that are academic, community and so on. Now I have been entrusted to lead the Department of History and Islamic Civilization as the Head of Department starting from Julai 2012 until April 30, 2020. In addition, I was also appointed as Ahli Lembaga Pengarah Universiti Islam Malaysia since 2019 and also now as Ahli Senat UIM. In 2022, I was appointed as Prof Madya in the same department and have now published more or less 250 publications in various academic mediums.